THE BUSINESS OF BIOTECH

47:40 Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary
Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

On this week's episode of the Business of Biotech, we talk with NervGen leaders Adam Rogers, M.D., and Rich Macary about NVG-291, a daily neuroreparative peptide designed to restore function in patients with spinal cord injuries.

ABOUT THE BUSINESS OF BIOTECH

Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.

FEATURED GUESTS

Apple Spotify   YouTube

MEET YOUR HOST

Ben ComerBen Comer is chief editor of Life Science Leader magazine. He has covered the biopharmaceutical, medtech and medical device industries for 15 years as a reporter and editor, and worked as a senior manager in PwC’s Health Research Institute.

LINKEDIN

Interested in joining us on air? Contact us

RECENT EPISODES

47:40 Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

Implementing A New CEO Strategy With NervGen's Adam Rogers, M.D. And Rich Macary

46:56 The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

58:36 Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

Biosimilars And Complex Medicines For All With RNA Therapeutics' Sarfaraz Niazi, Ph.D.

40:29 Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

Radiotherapeutics For Neuroendocrine Tumors With Perspective Therapeutics' Thijs Spoor

55:44 Investing In Early-Stage Oncology With Yosemite's Dan McHugh

Investing In Early-Stage Oncology With Yosemite's Dan McHugh

51:00 Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

Commercializing CAR T Cell Therapy With Legend Biotech's Alan Bash

54:03 Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

Radiotherapeutics For CNS Cancers With Plus Therapeutics' Marc Hedrick, M.D.

48:33 Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

Developing Novel Cancer Drugs On A Budget With Iterion Therapeutics' Rahul Aras, Ph.D.

54:00 Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

Making Biologics Orally Available With Vivtex's Thomas von Erlach, Ph.D.

58:19 An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

An Anthropological Lens On Leadership In Life Sciences With Bunka's Monika Sumra, Ph.D.

More Recent Episodes

FINANCE & CAPITAL MARKETS

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

35:59 24_01_BoB_1280x720_Ep5

Episode 5: Finding Funding In Volatile Times With Ben Zeskind

57:48 24_01_BoB_1280x720_Ep174

The Legend Steve Gorlin's Golden Rules

35:37 24_01_BoB_1280x720_Ep3

Episode 3: The Biopharma Exit Strategy With Dr. Francois Nader

53:44 24_01_BoB_1280x720_Ep128

Financing Biopharma Innovation With Allan Shaw

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

51:32 Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

1:02:44 24_01_BoB_1280x720_Ep177

Biotech Dealmaking with Regeneron's Nouhad Husseini

46:21 24_01_BoB_1280x720_Ep80

Venture Philanthropy For Type 1 Diabetes With T1D Fund's Katie Ellias

49:47 24_01_BoB_1280x720_Ep183

Art Of The Pivot With Elevation Oncology's Joe Ferra

More on Finance & Capital Markets

DISCOVERY

58:11 How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

43:34 24_01_BoB_1280x720_Ep121

Leveraging Lymph Nodes With Elicio's Dr. Peter DeMuth

39:02 24_01_BoB_1280x720_Ep40

Supercharging An ADC Program With SOTIO CEO Dr. Radek Špíšek

37:53 24_01_BoB_1280x720_Ep114

IDO Target Perseverence With IO Biotech's Mai-Britt Zocca, Ph.D.

53:15 24_01_BoB_1280x720_Ep126

The Antibody Engine With Abpro's Chan Brothers

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

50:45 24_01_BoB_1280x720_Ep45

Med Device Meets Biopharma With OncoSec's Dan O'Connor, J.D.

40:38 24_01_BoB_1280x720_Ep190

Precision Radiopharmaceuticals with Ratio's Jack Hoppin, Ph.D.

1:02:28 24_01_BoB_1280x720_Ep171

Bio Career Moves With Codagenix's Johanna Kaufmann, Ph.D.

More on Discovery

REGULATORY

37:05 BoB_Ep30_2

Keeping Cell Therapy Clinicals On The Rails With Brian Culley

1:06:51 BoB_Ep98_2

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D.

46:56 The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

The Impact Of FDA Risk On Biotech Rewards With CFO And Board Director Allan Shaw

47:28 24_01_BoB_1280x720_Ep117

IND For TIL Therapy With Obsidian Therapeutics' Paul Wotton, Ph.D.

42:39 Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

Bringing Curative Cell Therapies To Market with Kite Pharma's Cindy Perettie

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

31:52 24_01_BoB_1280x720_Ep130

Dissecting Spesolimab's Approval With Boehringer Ingelheim's Carine Boustany

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

39:26 24_01_BoB_1280x720_Ep16

Data Quality & Master Files With Dr. Robert Hariri

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

More on Regulatory